Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Use of diuretics in heart failure and cirrhosis.

Schrier RW.

Semin Nephrol. 2011 Nov;31(6):503-12. doi: 10.1016/j.semnephrol.2011.09.005. Review.

PMID:
22099507
2.

Pathogenesis and management of sodium and water retention in cardiac failure and cirrhosis.

Schrier RW, Gurevich AK, Cadnapaphornchai MA.

Semin Nephrol. 2001 Mar;21(2):157-72. Review.

PMID:
11245778
3.

Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.

Schrier RW.

Am J Med. 2006 Jul;119(7 Suppl 1):S47-53. Review.

PMID:
16843085
4.

Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?

Bansal S, Lindenfeld J, Schrier RW.

Circ Heart Fail. 2009 Jul;2(4):370-6. doi: 10.1161/CIRCHEARTFAILURE.108.821199. Review.

5.

Edematous disorders: pathophysiology of renal sodium and water retention and treatment with diuretics.

Abraham WT, Schrier RW.

Curr Opin Nephrol Hypertens. 1993 Sep;2(5):798-805. Review.

PMID:
7922221
6.

Pathophysiology of vasopressin in edematous disorders.

Schrier RW, Howard RL.

Nihon Naibunpi Gakkai Zasshi. 1989 Dec 20;65(12):1311-27. Review.

PMID:
2697604
7.

[Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure].

Christ M, Ludwig N, Maisch B.

Herz. 2002 Mar;27(2):135-49. Review. German.

PMID:
12025459
8.

A unifying hypothesis of sodium and water regulation in health and disease.

Howard RL, Schrier RW.

Horm Res. 1990;34(3-4):118-23.

PMID:
2104396
9.

[Mechanisms of renal retention of sodium and water in heart failure, cirrhosis and pregnancy].

Knotek M, Rogachev B, Ohara M, Schrier RW.

Lijec Vjesn. 2000 Jan-Feb;122(1-2):20-6. Review. Croatian.

PMID:
10916353
10.

Update in diuretic therapy: clinical pharmacology.

Brater DC.

Semin Nephrol. 2011 Nov;31(6):483-94. doi: 10.1016/j.semnephrol.2011.09.003. Review.

PMID:
22099505
11.
12.

[Diuretic therapy in congestive heart failure--new views on spironolactone therapy].

Haller C.

Ther Umsch. 2000 Jun;57(6):374-9. Review. German.

PMID:
10894022
13.

Diuretic management in heart failure.

Michael Felker G.

Congest Heart Fail. 2010 Jul;16 Suppl 1:S68-72. doi: 10.1111/j.1751-7133.2010.00172.x. Review.

14.

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rod├ęs J.

Hepatology. 1988 Sep-Oct;8(5):1151-7. Review.

PMID:
2971015
15.

Ascites in liver diseases.

Gentilini P, Laffi G.

Ann Ital Med Int. 1991 Jan-Mar;6(1 Pt 2):148-55. Review.

PMID:
1742150
16.

Novel strategies: challenge loop diuretics and sodium management in heart failure--Part I.

Pasquale PD, Sarullo FM, Paterna S.

Congest Heart Fail. 2007 Mar-Apr;13(2):93-8. Review.

17.

Hyponatremia in cirrhosis: pathophysiology and management.

John S, Thuluvath PJ.

World J Gastroenterol. 2015 Mar 21;21(11):3197-205. doi: 10.3748/wjg.v21.i11.3197. Review.

18.
19.

Pathogenesis of water and sodium retention in cirrhosis.

Martin PY, Schrier RW.

Kidney Int Suppl. 1997 Jun;59:S43-9. Review.

PMID:
9185104
20.

Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture.

Ring-Larsen H, Henriksen JH, Wilken C, Clausen J, Pals H, Christensen NJ.

Br Med J (Clin Res Ed). 1986 May 24;292(6532):1351-3.

Supplemental Content

Support Center